Tecnovatica S.A. (WSE:TEC)

Market Cap	15.10M +325.8%
Revenue (ttm)	231.55K
Net Income	-89.63K
EPS	-0.01
Shares Out	35.04M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	374
Open	0.4570
Previous Close	0.4200
Day's Range	0.4310 - 0.4570
52-Week Range	0.2600 - 0.8560
Beta	0.39
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 16, 2026

About Tecnovatica

Tecnovatica S.A. does not have significant operations. Previously, it engaged in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets. The company was formerly known as Vinci Gen S.A. and changed its name to Tecnovatica S.A. in January 2026. Tecnovatica S.A. was founded in 2010 and is headquartered in Koszalin, Poland.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Employees: 1
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: TEC

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Nov 9, 2026

Data Sources Report a data error